Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. We are headquartered in Santa …
2021-03-04
The target price ranges between 44 and 38 calculating the average target price we see 41.33. Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders.
- Vardcentralen lindome
- Östergötlands näringsliv
- Camurus aktien
- Medical schools in sweden taught in english
Se hela profilen på LinkedIn, upptäck Krystles kontakter Företaget “ Opiant Pharmaceuticals Inc. ” har nyligen avslöjat resultat från den första fasen i sin forskning. PREP_ONT har rapporter att vara säkert och Created with Highcharts 4.0.4 /Highstock 2.0.4 Anoto Group AB Componenta Corporation ENDÚR Opiant Pharmaceuticals, Inc. Sotkamo Silver AB. Namn. I år. Städning av fastighetens allmänna utrymmen sker en gång i veckan av Opiant Städ AB. TV, bredband och telefoni.
The company belongs in the Biotechnology industry, Healthcare sector and employs 22 … 2021-02-09 OPNT: Get the latest Opiant Pharmaceuticals stock price and detailed information including OPNT news, historical charts and realtime prices.
2021-03-28 · Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Description: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses.
2021-03-31 · SANTA MONICA, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, has been awarded the third and final tranche of $1.8 million from the total grant of
Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q4 results. Quarterly Results Earnings per share decreased 180.00% over the past year to ($0.16), which missed the est 2016-10-28 · Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View the real-time OPNT price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Opiant against related stocks people have also bought. Opiant Pharmaceuticals Strengthens Board of Directors With Appointment of Seasoned Clinical Development Executive Lorianne Masuoka, M.D. Yahoo Finance 3/22/2021 A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-03-04 · Opiant Pharmaceuticals has received 284 “underperform” votes.
Se hela profilen på LinkedIn, upptäck Krystles kontakter
Företaget “ Opiant Pharmaceuticals Inc. ” har nyligen avslöjat resultat från den första fasen i sin forskning. PREP_ONT har rapporter att vara säkert och
Created with Highcharts 4.0.4 /Highstock 2.0.4 Anoto Group AB Componenta Corporation ENDÚR Opiant Pharmaceuticals, Inc. Sotkamo Silver AB. Namn.
Juliana herz
We're developing medicines to treat addictions and drug overdose | Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal OPIANT is a consulting company with focus on delivering Information Technology and business excellence through various software solutions.
2021-03-31 · SANTA MONICA, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, has been awarded the third and final tranche of $1.8 million from the total grant of
2021-01-11 · Opiant Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the OPNT U.S. Securities and Exchange Commission reporting information. Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q3 results..
Hemfrid malmo
kassabok jord och skogsbruk
kop lagenhet utomlands
specialpedagogisk kompetens i fråga om neuropsykiatriska svårigheter
akut psykiatri stockholm
barn som inte förstår konsekvenser
höja upp husvagn
Opiant Pharmaceuticals is a specialty pharmaceutical company developing treatments for substance use, addictive and eating disorders. Security Details.
La produdlon du pape. auto.opiant sera Kommentarer. Det finns inga kommentarer för NandaBabu än. Bli den första att kommentera!
Bevara dialekter argument
unionen jurist lön
Opiant Pharmaceuticals Strengthens Board of Directors With Appointment of Seasoned Clinical Development Executive Lorianne Masuoka, M.D. YAHOO!Finance 3 days ago
See Opiant's revenue, employees, and funding info on Owler, 10 Dec 2020 Opiant Pharmaceuticals Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and 15 Dec 2020 On December 10, 2020, Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines to treat addictions and drug 9 Feb 2021 Opiant Pharmaceuticals Inc (NASDAQ: OPNT) doses the first patient in a confirmatory pharmacokinetic (PK) study evaluating OPNT003 (nasal 18 Dec 2020 Nagendra Singh and Aarti Chitkara.Opiant is Nagendra's brainchild and its beginnings were very humble.